Literature DB >> 30149902

Serum CK 18-M30 reflect liver pathological severity during NAFLD progression in a rat model.

Li Xue1, Xiaolan Lu2, Juntao He1, Ting Zhang3, Xiaokang Wu1, Yanping Zhang1, Ningning Wang4, Zhe An1, Jiru Xu5, Yan Geng6.   

Abstract

BACKGROUND: CK 18-M30 was increased in patients with NAFLD. However, little is known about the relationship between CK 18-M30 and NAFLD progression. We aimed to analyze the variety of CK 18-M30 and other metabolism indices during NAFLD progression. Meanwhile, we aimed to investigate the correlation between CK 18-M30 and liver pathology during NAFLD progression.
MATERIALS AND METHODS: Rats were fed with high sucrose and high fat diet for building NAFLD models. We detected liver pathology by hematoxylin-eosin (HE) staining. We also detected serum CK 18-M30 and metabolism indices including liver enzymes, serum lipids and glycometabolism indices.
RESULTS: The aggravating degree of liver pathology appeared with prolonged feeding period. The relevance of CK 18-M30 to the severity of liver pathology were higher relative to other indices.
CONCLUSION: Our results suggested the significance of CK 18-M30 in the progression of NAFLD and provided new evidence for the early diagnosis and prognostic estimation of NAFLD.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cytokeratin 18; Liver pathological severity; Nonalcoholic fatty liver; Routine clinico-biological indices

Mesh:

Substances:

Year:  2018        PMID: 30149902     DOI: 10.1016/j.prp.2018.08.016

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  1 in total

1.  Atorvastatin promotes AMPK signaling to protect against high fat diet-induced non-alcoholic fatty liver in golden hamsters.

Authors:  Bin Zhang; Chenyang Zhang; Xuelian Zhang; Nannan Li; Zhengqi Dong; Guibo Sun; Xiaobo Sun
Journal:  Exp Ther Med       Date:  2020-01-22       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.